Stem cell therapy does not cure arthritis or regrow missing cartilage. It is an experimental treatment for managing local inflammation and increasing mobility. Most patients achieve significant pain relief for 2 to 5 years, though advanced bone-on-bone cases still require joint replacement surgery.
- Treatment goal: Clinical outcomes focus on reducing chronic inflammation and managing joint pain.
- Typical candidates: Procedures show best results for younger patients with mild cartilage damage.
- Symptom relief: Benefits generally last 2 to 5 years before requiring repeat injections.
- Regulatory status: Listed as an experimental, off-label procedure by major global health authorities.
Bookimed Expert Insight: Spain attracts many professional athletes, including FC Barcelona players, to clinics like Centro Médico Teknon for regenerative treatments. While the $6,000 to $11,000 cost is higher than some regions, these facilities are JCI-accredited and led by researchers like Dr. Luís Orozco Delclós. High patient volumes of 10,000 people annually suggest a high level of procedural refinement, even if the therapy remains a management tool rather than a permanent cure.
Patient Consensus: Most patients describe the procedure as managing symptoms better rather than providing a miracle fix. They emphasize that while pain decreases significantly, it is vital to view this as a way to delay surgery rather than skip it entirely.
